Dr. Ignazio Garaguso

Lead the sales and business development of liquid chromatography-mass spectrometry (LC-MS) systems, consumables, software and services within the food safety, clinical diagnostics and environmental testing markets. Design and development of marketing strategies, content and implementation of marketing campaigns and sales activities, in close collaboration with local sales organisations, to penetrate target markets and achieve operational objectives.

Leading the business development of PerkinElmer for LC-MS in EMEA and India Creation, implementation and monitoring of annual operating program. Design and execution of Demand Generation activities and marketing programs, Collect and analyse market trends to define and develop targeted applications and solutions, liaise across business units, regional organisations and business partners to deliver market and financial objectives

Promoted to lead sales development and marketing of the whole product portfolio of systems, consumables, software and services for the clinical research, diagnostics and forensic toxicology markets. Coordination and implementation of right-to-win product/solutions strategies by working across corporate divisions, regional organisations, and business partners to deliver market and financial objectives. In addition to responsibilities below, coordination of 11 regional specialists.

-Drive sales and marketing actives of consumables to increase market share in the clinical and bioanalysis segments. -Identify and develop new applications for Waters clinical research and in-vitro diagnostic (IVD) total solutions. -Planning and implementing marketing campaigns -Representing the Voice of the Customer (VoC) prioritizing issues and evaluate new solutions. -Empowering the sales teams to operate effectively through the creation of sales tools and sales training.

This position combines sales, marketing and technical skills to search, define, promote and sell separation sciences products, to ensure optimal sales results for the development of the OMNILAB business. Market segments include: pharmaceutical/biotechnology companies, forensic, toxicological and environmental testing labs, clinical diagnostic labs, university, grant-funded science research institutions.

Molecular Toxicology Dept. mass spectrometry & proteomics . Project: -Development of mass spectrometric based method for the Analysis of polycyclic aromatic hydrocarbons (PAH)-DNA adducts. -Protein posttranslational modifications (PTM) in lung tissue to assess their alterations in lung adenocarcinomas.

R&D projects for development of different Proteomic approaches for identification and characterization of bacterial membranes protein, with the goal to develop vaccines against infections caused by Neisseria Meningitidis, Chlamydia Pneumoniae, Streptococcus group A and B.

Cloning and analysis of target dependent genes involved in cell transformation, apoptosis and defence against genotoxic agents. (The project was part of the “European biomedicine and health program”). Cloning of heterologous genes and transformation/transfection in bacteria/eukaryotic cell, PCR, recombinant proteins purification, HPLC, cell culture.

Freelancer regional area sales representative. Pharmaceutical products. Some of the represented companies: Haleko S.r.l. (dietetic and fitness supplements), Pegaso S.r.l., Vepro S.r.l. (phytotherapeutics), Helan S.r.l. (cosmetics) Nuova Fiori Del Sud S.r.l. (essential oils). • Results: successfully consolidated the existing client base and accounted new customers. Consistently exceed the marketing plan goals by at lest 15% per year.

Mass spectrometry (MALDI-TOF, ESI-Q-TOF, ESI-IT), Liquid Chromatogrphy, nano LC, Proteomics, Protein posttranslational modifications, DNA adducts

Molecular biology, biochemistry, bioinformatics

Physical chemistry, organic chemistry, Gas Chromatography